Suppr超能文献

莫匹罗星治疗皮肤感染:来自中国的临床经验。

Mupirocin for Skin Infection: Clinical Experience from China.

作者信息

Sun Jing, Lu Tracy, Dang Yan, Xu Zigang, Liu Ying

机构信息

Medical & Scientific Affairs, Haleon (Formerly GSK Consumer Healthcare), Shanghai, People's Republic of China.

Department of Dermatology, Beijing Children's Hospital, Capital Medical University, National Key Discipline of Pediatrics, Key Laboratory of Major Diseases in Children, Ministry of Education, National Center for Children's Health, Beijing, People's Republic of China.

出版信息

Infect Drug Resist. 2024 Sep 13;17:3955-3966. doi: 10.2147/IDR.S475611. eCollection 2024.

Abstract

Mupirocin, an antibiotic produced by , is mainly used for the topical treatment of various skin and soft tissue infections caused by (including methicillin-resistant ) and around the world for decades. Nevertheless, the clinical application scope of mupirocin varies in different countries due to differences in their medical policies, prescription types, and drug resistance. According to the experience of Chinese doctors in the past few years, mupirocin presented low drug resistance rates, and could be used as a treatment option for various primary infections and secondary infections, with antibacterial effects in a broad application. In this review, we summarized the experience of mupirocin used in the Chinese population and discussed its clinical value to provide novel insights and inspiration for physicians.

摘要

莫匹罗星是由[具体产生菌]产生的一种抗生素,几十年来在全球主要用于局部治疗由[具体病原菌](包括耐甲氧西林的[具体病原菌])引起的各种皮肤和软组织感染。然而,由于各国医疗政策、处方类型和耐药性的差异,莫匹罗星的临床应用范围在不同国家有所不同。根据中国医生过去几年的经验,莫匹罗星呈现出较低的耐药率,可作为各种原发性感染和继发性感染的治疗选择,在广泛应用中具有抗菌作用。在本综述中,我们总结了莫匹罗星在中国人群中的使用经验,并讨论了其临床价值,为医生提供新的见解和启发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0a8/11407312/4148b76cd13f/IDR-17-3955-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验